Skip to content

Pilot Study of Liver Fibrosis Stage Assessment by Fibroblast Activation Protein Imaging in Patients With Biopsy for Suspected or Proven Nonalcoholic Steatohepatitis

Status
Recruiting
Phases
Phase 2
Study type
Interventional
Source
EU CTIS
Registry ID
CTIS2024-511788-27-01
Enrollment
72
Registered
2025-03-10
Start date
2025-06-03
Completion date
Unknown
Last updated
2025-03-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

non-alcoholic hepatic steatosisalcoholic hepatic steatosis

Brief summary

Measurement of 68Ga-FAPI-46 uptake intensity, with Standardized Uptake Values maximum (SUVmax), average (SUVmean) and peak (SUVpeak), in areas centered on biopsy sites, the reference then being a classification of fibrosis stages determined by centralized biopsy rereading (stages 4, 3, 2 and < 2 (Kleiner, 2005; Bedossa, 2012).

Detailed description

1. SUV threshold values associated with each of the four fibrosis histological stage groups (stages 4, 3, 2 and < 2) by the naive Bayes classifier., 2. Location of the uptake zone with maximum activity (SUVmax and SUVPIC zones, respectively), and of the homogeneity of SUV distribution over the liver volume (histogram of liver voxels per SUV value category)., 3. Search, on whole-body images, for 68Ga-FAPI-46 uptake foci located outside the tracer's normal elimination zones (urinary excretory tracts), and which may correspond to abnormal areas of fibrosis and/or inflammation, or even cancer (this new tracer has already demonstrated a good ability to detect many cancers)., 4. Intra-class correlation coefficients and their 95% confidence intervals., 5. Variation in the degree of prediction of the four groups of histological stages of fibrosis when the 68Ga-FAPI-46 PET/CT variables are added to the variables derived from the usual clinico-biological scores (CBC, FIB-4, Fibrometer) and pulse elastometry (Fibroscan®)., 6. Identical to the main objective, the reference being the histological fibrosis score determined in the SAF score, and patients being grouped into quartiles according to this score.

Interventions

None listed

Sponsors

CHRU De Nancy
Lead SponsorOTHER

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Design outcomes

Primary

MeasureTime frame
Measurement of 68Ga-FAPI-46 uptake intensity, with Standardized Uptake Values maximum (SUVmax), average (SUVmean) and peak (SUVpeak), in areas centered on biopsy sites, the reference then being a classification of fibrosis stages determined by centralized biopsy rereading (stages 4, 3, 2 and < 2 (Kleiner, 2005; Bedossa, 2012).

Secondary

MeasureTime frame
1. SUV threshold values associated with each of the four fibrosis histological stage groups (stages 4, 3, 2 and < 2) by the naive Bayes classifier., 2. Location of the uptake zone with maximum activity (SUVmax and SUVPIC zones, respectively), and of the homogeneity of SUV distribution over the liver volume (histogram of liver voxels per SUV value category)., 3. Search, on whole-body images, for 68Ga-FAPI-46 uptake foci located outside the tracer's normal elimination zones (urinary excretory tracts), and which may correspond to abnormal areas of fibrosis and/or inflammation, or even cancer (this new tracer has already demonstrated a good ability to detect many cancers)., 4. Intra-class correlation coefficients and their 95% confidence intervals., 5. Variation in the degree of prediction of the four groups of histological stages of fibrosis when the 68Ga-FAPI-46 PET/CT variables are added to the variables derived from the usual clinico-biological scores (CBC, FIB-4, Fibrometer) and pulse

Countries

France

Outcome results

None listed

Source: EU CTIS · Data processed: Feb 4, 2026